FIELD: medicine.
SUBSTANCE: in patient's blood serum one should detect antibodies to nonstructural early DNA-binding proteins of herpes simplex virus type I and II and alpha-interferon in lacrimal liquid of a sick eye and at availability of these antibodies in blood serum to nonstructural early DNA-binding viral antigens and at the absence of alpha-interferon in lacrimal liquid of a sick eye one should determine the indications to perform therapy with alpha-interferon preparations.
EFFECT: higher efficiency of therapy.
2 ex, 1 tbl
| Title | Year | Author | Number | 
|---|---|---|---|
| RISK PREDICTION METHOD FOR RECURRENCE OF HERPES-ASSOCIATED EYE DISEASES | 2007 | 
 | RU2345366C1 | 
| METHOD OF DIAGNOSTICS OF MIXED CHRONIC RECURRENT EYE INFECTIONS BY PCR METHOD | 2017 | 
 | RU2658206C1 | 
| METHOD OF DIAGNOSING HYPERVIRUS EYE DISEASES | 2006 | 
 | RU2400756C2 | 
| USE OF LIOPHILISED PREPARATION OF ALLOFIBROBLASTS FOR TREATING HERPES VIRUS DISEASES | 2012 | 
 | RU2483739C1 | 
| METHOD FOR CHOOSING PATHOGENETICALLY CAUSED THERAPEUTIC APPROACH TO VIRAL OCULAR DISEASES | 2012 | 
 | RU2494741C1 | 
| METHOD OF SELECTING THERAPY OF CHRONIC INFLAMMATORY DISEASES OF EYE SURFACE BASED ON CONTROLLED POTENTIATION OF EXUDATIVE REACTION BY MEANS OF MECHANICAL OR IMMUNE IMPACT | 2009 | 
 | RU2421193C2 | 
| METHOD FOR TREATING THE CASES OF ULCERATED HERPETIC KERATITIS | 2001 | 
 | RU2192898C1 | 
| METHOD FOR PREDICTION OF MANIFESTATION OF FOETAL HERPES VIRAL INFECTION IN NEWBORNS | 2011 | 
 | RU2477484C1 | 
| DRUG | 1996 | 
 | RU2120294C1 | 
| METHOD FOR PREDICTING RISK OF RETINAL DETACHMENT DEVELOPMENT IN CASES OF PERIPHERAL AND POSTERIOR UVEITES IN CHILDREN | 2000 | 
 | RU2172957C1 | 
Authors
Dates
2005-08-10—Published
2004-02-20—Filed